Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

127.00p
   
  • Change Today:
      0.50p
  • 52 Week High: 139.50
  • 52 Week Low: 96.00
  • Currency: UK Pounds
  • Shares Issued: 104.77m
  • Volume: 75,554
  • Market Cap: £133.06m
  • RiskGrade: 95

Cello shares off key as pre-tax profits halved

By Frank Prenesti

Date: Wednesday 16 Sep 2015

LONDON (ShareCast) - (ShareCast News) - Shares in healthcare marketing company Cello Group plunged as interim pre-tax profits halved on the back of an ongoing tax dispute with the UK government and an expansion of its US activities.
Pre-tax profits at the media advisory firm slumped to £1.7m in the six months to 30 June on revenues of £77m compared with £78.3m last time. Administrative expenses rose to £40m from £35.8m.

Cello made a £1.1m provision in relation to a dispute with the taxman over the way one of its divisions charged VAT to charity sector clients.

The company added that other industry-wide issues have been informally raised by Revenue and Customs (HMRC) that "contradict their recent policy guidance".

"If these issues are eventually upheld by HMRC Policy, then the group and its advisors will vigorously contest them," Cello said in a statement.

The interim dividend is 0.84p, up from 0.80p.

Chief executive Mark Scott said the company's progress as an advisor to the pharmaceutical and biotech industry is "progressing at a rapid pace".

He said this was being driven by continuing strong growth from the core healthcare business, most notably in the US.

Shares in Cello were down 8% to 85.5p at 1101 BST.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cello Health Market Data

Currency UK Pounds
Share Price 127.00p
Change Today 0.50p
% Change 0.40 %
52 Week High 139.50
52 Week Low 96.00
Volume 75,554
Shares Issued 104.77m
Market Cap £133.06m
RiskGrade 95

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
67.63% below the market average67.63% below the market average67.63% below the market average67.63% below the market average67.63% below the market average
48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average
Price Trend
9.70% above the market average9.70% above the market average9.70% above the market average9.70% above the market average9.70% above the market average
15.00% above the sector average15.00% above the sector average15.00% above the sector average15.00% above the sector average15.00% above the sector average
Income
10.57% above the market average10.57% above the market average10.57% above the market average10.57% above the market average10.57% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Growth
32.64% below the market average32.64% below the market average32.64% below the market average32.64% below the market average32.64% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  Interim Final
Ex-Div 03-Oct-19 25-Apr-19
Paid 01-Nov-19 24-May-19
Amount 1.15p 2.75p

Trades for 20-Sep-2019

Time Volume / Share Price
17:07 3,000 @ 127.00p
16:00 6,300 @ 126.50p
15:58 3,000 @ 127.28p
15:54 3,939 @ 126.92p
15:33 3,500 @ 126.92p

Cello Health Key Personnel

CEO Mark Scott

Top of Page